The National Agency for Food and Drugs Administration and Control has warned the public against the use of Benylin Paediatric Syrup manufactured by Johnson & Johnson.
This development followed the recent laboratory findings indicating toxicity in the product.
According to NAFDAC, laboratory analysis carried out on the affected lot, the presence of Diethylene Glycol discovered was disturbing which generated concerns over its safety.
NAFDAC noted that, Diethylene Glycol, a known toxic substance, can have severe consequences upon ingestion, including abdominal pain, vomiting, and acute kidney injury, which can be fatal.
Benylin Paediatric Syrup is commonly used for alleviating cough and its associated symptoms, as well as treating hay fever and other allergic conditions in children aged 2 to 12 years.
Benylin Paediatric with the batch no: 329304 was manufactured in May 2021 and expires April 2024.
NAFDAC pointed out the importance of caution and vigilance among importers, distributors, retailers, and consumers throughout the supply chain to prevent the importation, distribution, sale, and use of substandard or contaminated regulated products.
Speaking further, the agency analysed the significance of buying medications only from certified and licensed suppliers, in order to ensure that their authenticity and physical condition are thoroughly checked.
It advised that , “Any individuals in possession of the affected product to stop its sale or use immediately and submit remaining stock to the nearest NAFDAC office.
“Furthermore, any adverse reactions observed following the use of this product should be promptly reported to qualified healthcare professionals for immediate medical attention
“Healthcare professionals and consumers are encouraged to report suspicions of substandard or falsified medicines to the nearest NAFDAC office or through various reporting channels provided by NAFDAC,” the agency said.
NAFDAC then directed the Marketing Authorisation Holder, Johnson and Johnson Company West Africa, to initiate the recall process for the affected batch, with notices to be uploaded to the WHO Global Surveillance and Monitoring System.
